[144] Alignment Healthcare, Inc. SEC Filing

Rhea-AI Filing Summary

Alignment Healthcare (ALHC) filed a Form 144 reporting a proposed sale of 380,000 shares of Common Stock through E-Trade, with an aggregate market value of $6,026,800 and an approximate sale date of 09/08/2025 on the Nasdaq Stock Market. The filer acquired 819,514 shares on 09/12/2022 via vesting of restricted stock units granted under the 2021 Equity Incentive Plan.

The filing also discloses recent sales executed under a Rule 10b5-1 plan by JEK Trust totaling 540,000 shares across four transactions in June–August 2025, with combined gross proceeds shown in the filing. The notice includes the standard signer representation about absence of undisclosed material adverse information.

Positive

• Planned sale disclosed: 380,000 shares with aggregate market value $6,026,800 identified for 09/08/2025
• Acquisition transparency: 819,514 shares were acquired via RSU vesting on 09/12/2022
• Prior 10b5-1 activity detailed: Sales of 540,000 shares during June–August 2025 with gross proceeds listed
• Compliance statement present: Standard signer representation regarding absence of undisclosed material adverse information

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice showing a planned sale of 380,000 shares and prior 10b5-1 sales totaling 540,000 shares.

The Form 144 is a standard disclosure that notifies the market of a proposed sale by an affiliate or insider. Key metrics are explicit: 380,000 shares planned for sale (aggregate market value $6,026,800) and prior 10b5-1 sales of 540,000 shares during June–August 2025. The filer reports acquisition of 819,514 shares via RSU vesting on 09/12/2022. There are no earnings, debt, or operational items in this filing; its investor relevance is transactional transparency rather than a change in fundamentals.

Corporate Governance Expert

TL;DR: Disclosure complies with Rule 144 and documents trading under a 10b5-1 plan; no governance issues disclosed.

The document provides the required seller representations and notes trading activity under an established Rule 10b5-1 plan for JEK Trust. It confirms the securities were acquired via RSU vesting and indicates compliance with disclosure norms. The filing contains no allegations, waivers, or governance changes and does not identify undisclosed material information.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	E-Trade Finance PO Box 101600 Arlington VA 22210-4600	380000	6026800	198031417	09/08/2025	Nasdaq Stock Market

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/12/2022	The Common Stock was acquired through the vesting of restricted stock units granted on 09/12/2022 under the Issuer's 2021 Equity Incentive Plan	Alignment Healthcare, Inc. (Issuer)			819514	09/12/2022	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	08/11/2025	180000	2627838
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	07/10/2025	180000	2413800
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	06/16/2025	90000	1302849
10b5-1 Sales Plan for JEK TRUST U/A DTD 02/08/2021 1100 W. Town & Country Road, Suite 1600 Orange CA 92868	Common Stock	06/11/2025	90000	1374201

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ALHC Form 144 disclose?

The filing discloses a proposed sale of 380,000 ALHC common shares (aggregate market value $6,026,800) with an approximate sale date of 09/08/2025.

How were the shares being sold acquired?

The filer acquired 819,514 shares on 09/12/2022 through the vesting of restricted stock units granted under the company's 2021 Equity Incentive Plan.

Has the filer sold ALHC shares recently?

Yes. The filing lists four 10b5-1 transactions by JEK Trust totaling 540,000 shares sold on 06/11/2025, 06/16/2025, 07/10/2025, and 08/11/2025 with gross proceeds shown for each sale.

Through which broker will the proposed sale be executed?

The planned sale is to be executed through E-Trade (address listed in the filing) on the Nasdaq Stock Market.

Does the Form 144 state any undisclosed material adverse information?

The signer represents that they do not know any material adverse information about the issuer that has not been publicly disclosed.

What percentage of outstanding shares does the planned sale represent?

The filing lists 198,031,417 shares outstanding; the planned sale of 380,000 shares represents approximately 0.19% of outstanding shares (calculation based on figures in the filing).